Status:
COMPLETED
Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease
Lead Sponsor:
AVB Biotechnology
Conditions:
COVID-19 Pneumonia
Virus Diseases
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Dr. Biolyse® is a device with artificial intelligence that works in sync with the immune system and can be integrated like an element of this system. It is designed to develop chemical immunity within...
Eligibility Criteria
Inclusion
- Men and women between the ages of 18-65
- Patients with mild moderate complicated or uncomplicated COVID 19 pneumonias
- Those who accept to be followed up and treated as an inpatient
- Those who have at least one laboratory and clinical finding that can be evaluated during follow-up
Exclusion
- Patients with severe course or COVID 19 pneumonia requiring intensive care follow-up
- Pregnant or breastfeeding women
- Epilepsy, Arrhythmia, Dementia, heart failure, severe lung disease, patients with active malignancy and those with pacemaker
- "Vulnerable Population" patients defined in ICU
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06113757
Start Date
September 1 2022
End Date
April 15 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bezmialem Vakif University Dragos Hospital
Istanbul, Turkey (Türkiye)